What's breaking now, across thousands of outlets.
Jennifer Taubert will step down after a lengthy run leading J&J’s pharmaceutical business. Elsewhere, pricing issues hampered what Wall Street analysts view as an otherwise strong gene therapy launch.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Cyclospora: Parasite back in the spotlight after two US deaths. Here's what to know about symptoms, transmission, risky foods and the situation in Europe.
The study is the most comprehensive review of dementia hospitalizations ever undertaken in the UK. The researchers outline how delayed discharges, lack of communication among NHS staff and hospital…
A study published in the Journal of Public Economics suggests that local dating markets shape pregnancy health. Having more available male partners is associated with stronger relationships, lower…
(MedPage Today) -- Ebola has killed more than 1,700 people in eastern Congo in the fastest-growing outbreak of the disease, data showed.
The first two cyclosporiasis-related deaths were reported in Michigan. This comes as Sen. Richard Blumenthal, a Democrat from Connecticut, calls for an investigation into Taylor Farms' connections to…
Former congressmen Joe Cunningham and JD Hayworth are urging Congress to codify the Most Favored Nation drug pricing policy into law via the Global Fairness in Drug Pricing Act to ensure Americans do…
